{"transactions":[{"id":2536397,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:42:32.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":1900,"price":30.9962,"value":58892.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $30.76 to $31.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":901215,"source":{"system":"sec-edgar","filing":"0001567619-21-018628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921018628/doc1.xml","form_type":"4"}},{"id":2536396,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:42:32.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":22820,"price":31.5581,"value":720155.842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $30.70 to $32.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":903115,"source":{"system":"sec-edgar","filing":"0001567619-21-018628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921018628/doc1.xml","form_type":"4"}},{"id":2536395,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:42:32.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":11565,"price":31.0221,"value":358770.5865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $30.27 to $32.07,inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":925935,"source":{"system":"sec-edgar","filing":"0001567619-21-018628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921018628/doc1.xml","form_type":"4"}},{"id":2554458,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T16:34:19.000Z","date":"2021-09-30","kind":"sale","acquired":false,"shares":4549,"price":27.2774,"value":124084.8926,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $27.08 to $27.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":937500,"source":{"system":"sec-edgar","filing":"0001567619-21-017751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017751/doc1.xml","form_type":"4"}},{"id":2554457,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T16:34:19.000Z","date":"2021-09-30","kind":"sale","acquired":false,"shares":7836,"price":26.6928,"value":209164.7808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $26.07 to $27.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":942049,"source":{"system":"sec-edgar","filing":"0001567619-21-017751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017751/doc1.xml","form_type":"4"}},{"id":2554456,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T16:34:19.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":700,"price":30.0631,"value":21044.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $29.75 to $30.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":949885,"source":{"system":"sec-edgar","filing":"0001567619-21-017751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017751/doc1.xml","form_type":"4"}},{"id":2554455,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T16:34:19.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":8365,"price":29.0565,"value":243057.6225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $28.71 to $29.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":950585,"source":{"system":"sec-edgar","filing":"0001567619-21-017751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017751/doc1.xml","form_type":"4"}},{"id":2554454,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T16:34:19.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":7806,"price":27.9928,"value":218511.7968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.70 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":958950,"source":{"system":"sec-edgar","filing":"0001567619-21-017751","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017751/doc1.xml","form_type":"4"}},{"id":2556604,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T16:05:11.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":100,"price":32,"value":3200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":966756,"source":{"system":"sec-edgar","filing":"0001567619-21-017624","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017624/doc1.xml","form_type":"4"}},{"id":2556603,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T16:05:11.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":13812,"price":30.5164,"value":421492.5168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":966856,"source":{"system":"sec-edgar","filing":"0001567619-21-017624","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017624/doc1.xml","form_type":"4"}},{"id":2556602,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T16:05:11.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":100,"price":34.19,"value":3419.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":980668,"source":{"system":"sec-edgar","filing":"0001567619-21-017624","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017624/doc1.xml","form_type":"4"}},{"id":2556601,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T16:05:11.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":6157,"price":33.5115,"value":206330.3055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":980768,"source":{"system":"sec-edgar","filing":"0001567619-21-017624","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017624/doc1.xml","form_type":"4"}},{"id":2556600,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T16:05:11.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":13075,"price":32.5871,"value":426076.3325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Since the date of the reporting person's last ownership report, he transferred 1,000,000 shares of FDMT common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":986925,"source":{"system":"sec-edgar","filing":"0001567619-21-017624","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921017624/doc1.xml","form_type":"4"}},{"id":2705573,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-19T20:34:24.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":26.89,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-21-010750","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000156761921010750/doc1.xml","form_type":"4"}},{"id":3238346,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-02T15:46:31.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":3620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":3620,"derivative":{"exercise_price":51.81,"expiration_date":"2030-02-27","underlying":"Ordinary Shares","underlying_shares":3620},"source":{"system":"sec-edgar","filing":"0000904454-20-000257","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445420000257/edgar.xml","form_type":"4"}},{"id":3238345,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-03-02T15:46:31.000Z","date":"2020-02-27","kind":"grant","acquired":false,"shares":2063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":46978,"source":{"system":"sec-edgar","filing":"0000904454-20-000257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445420000257/edgar.xml","form_type":"4"}},{"id":3297750,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-30T21:06:01.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":806,"price":62.27,"value":50189.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $61.50 to $62.39.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44915,"source":{"system":"sec-edgar","filing":"0000904454-20-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445420000112/edgar.xml","form_type":"4"}},{"id":3682676,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-30T17:24:39.000Z","date":"2019-01-28","kind":"sale","acquired":false,"shares":1210,"price":31.31,"value":37885.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $31.26 to $31.36.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45721,"source":{"system":"sec-edgar","filing":"0000904454-19-000130","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445419000130/edgar.xml","form_type":"4"}},{"id":3683909,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-29T20:32:14.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":5295,"derivative":{"exercise_price":31.71,"expiration_date":"2029-01-25","underlying":"Ordinary Shares","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0000904454-19-000109","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445419000109/edgar.xml","form_type":"4"}},{"id":3683908,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-29T20:32:14.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":46931,"source":{"system":"sec-edgar","filing":"0000904454-19-000109","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445419000109/edgar.xml","form_type":"4"}},{"id":3683907,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-29T20:32:14.000Z","date":"2019-01-17","kind":"sale","acquired":false,"shares":7500,"price":30.71,"value":230325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":43701,"source":{"system":"sec-edgar","filing":"0000904454-19-000109","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445419000109/edgar.xml","form_type":"4"}},{"id":4083624,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-01-31T10:30:09.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":2878,"price":18.53,"value":53329.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.41 to $18.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15314,"source":{"system":"sec-edgar","filing":"0000904454-18-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445418000087/edgar.xml","form_type":"4"}},{"id":4084900,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-30T10:42:08.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":6390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":6390,"derivative":{"exercise_price":19.39,"expiration_date":"2028-01-26","underlying":"Ordinary Shares","underlying_shares":6390},"source":{"system":"sec-edgar","filing":"0000904454-18-000062","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445418000062/edgar.xml","form_type":"4"}},{"id":4084899,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-01-30T10:42:08.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 5,000 restricted share units that vested in full on January 27, 2017 previously disclosed by the Reporting Person in Table II and (ii) 11,000 restricted share units that vested in full on January 27, 2018 previously disclosed by the Reporting Person in Table II.  Adjusted to reflect the sale on January 30, 2017 of 2,600 shares to satisfy tax withholding obligations in connection with the vesting of restricted share units, the proceeds of which were remitted to the Issuer, as required by the relevant Restricted Share Unit Agreement."}],"balance_after":18192,"source":{"system":"sec-edgar","filing":"0000904454-18-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000090445418000062/edgar.xml","form_type":"4"}},{"id":4475531,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-31T15:02:05.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Unit vests 100% on January 27, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests."}],"balance_after":16000,"derivative":{"exercise_price":0,"exercise_date":"2020-01-27","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001140361-17-003702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000114036117003702/doc1.xml","form_type":"4"}},{"id":4475530,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":134302,"kind":"person","name":"SCHAFFER DAVID","position":1,"cik":"0001692929","reported_name":"SCHAFFER DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T15:02:05.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests 100% on January 27, 2018."}],"balance_after":11000,"derivative":{"exercise_price":5.37,"expiration_date":"2027-01-27","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001140361-17-003702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692929/000114036117003702/doc1.xml","form_type":"4"}}]}